Company / Cash & Equivalents
Merit Medical Systems, Inc. Cash & Equivalents History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$446.4M
FY2025
5-year range
$56.9M / $587.0M
FY2021-FY2025
Trend
+18.5%
vs FY2024
Sector context
#51 of 148
Health Care
What the data says
At $446M, Merit Medical Systems, Inc.'s cash & equivalents ranks #51 of 148 in the Health Care sector. Cash & Equivalents has fluctuated over the past 10 years, ranging from $4M in FY2017 to $587M in FY2023.
Based on SEC 10-K filings.
$446M in FY2025 with a 5-year CAGR of +51.0%.
Declined from $587M to $446M over the past 2 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- +97.0%
- 5-Year CAGR
- +51.0%
- 10-Year CAGR
- -
Sector benchmark
#51 of 148 in Health CareTop 34% of 148This company $446.4M Sector average $1.2B
▼
-62.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +51.0%, indicating consistent growth.
- In FY2025, cash & equivalents increased 18.5% year-over-year.
- Ranks #51 out of 148 companies in the Health Care sector.
- Peak cash & equivalents was recorded in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $446.4M | +18.5% |
| FY2024 | $376.7M | -35.8% |
| FY2023 | $587.0M | +905.1% |
| FY2022 | $58.4M | +2.6% |
| FY2021 | $56.9M | +0.0% |
| FY2020 | $56.9M | +28.4% |
| FY2019 | $44.3M | -34.2% |
| FY2018 | $67.4M | +1512.6% |
| FY2017 | $4.2M | -43.2% |
| FY2016 | $7.4M | -1.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026